Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Effect on Exercise Endurance in COPD
NCT00620022Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Apr 2008; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00620022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620022.